.gif)
_web.gif)
Table of Contents
Cover
| Cover | |
Contents
| Contents | |
| 150-151 |
From the Editor
| Patient autonomy or patient confusion? | |
| Bridget Farham | 152 |
Editor's choice
| Editor's Choice | |
| Janet Seggie | 153 |
Correspondence
| Reducing the surgical complications of smoking by cotinine testing | |
| D J Potgieter, G dos Passos, C E Price, A D Rogers | 154-155 |
| A path to full-service contracting with general practitioners under National Health Insurance | |
| Shabir Moosa | 155-156 |
| Primary prevention of rheumatic fever in children: Key factors to consider | |
| Andrew Steer, Margie Danchin, James H Irlam, Bongani M Mayosi, Mark E Engel, Thomas A Gaziano, Andrew C Whitelaw | 156-157 |
| A balanced approach to interpreting the WHIRCDMT | |
| Patrick B Wilson | 157-158 |
Izindaba
| From coal-face clinicians to change agents – igniting healthcare innovation | |
| 159-160 |
| Annually, 1% of gold miners die – 4% sent home sick | |
| 160-162 |
Obituaries
| Hymie Gaylis | |
| Norman Albert Blumberg | 163 |
| Dennis James Pudifin | |
| Yackoob Kassim Seedat | 163 |
Forum
| Clinical Access Program for Bedaquiline for the treatment of drug-resistant tuberculosis | |
| Francesca Conradie, Graeme Meintjes, Jennifer Hughes, Gary Maartens, Hannetjie Ferreira, Sweetness Siwendu, Iqbal Master, Norbert Ndjeka | 164-166 |
| Recommendations pertaining to the use of viral vaccines: Influenza 2014 | |
| S Walaza | 166-167 |
| Cardiovascular prevention: Lifestyle and statins – competitors or companions? | |
| Lionel Henry Opie, Anthony John Dalby | 168-173 |
| Isoniazid preventive therapy for tuberculosis in South Africa: An assessment of the local evidence base | |
| Robin Wood, Linda-Gail Bekker | 174-177 |
| The research ethics evolution: From Nuremberg to Helsinki | |
| Ames Dhai | 178-180 |
Editorial
| New imaging approaches for improving diagnosis of childhood tuberculosis | |
| Sabine Bélard, Savvas Andronikou, Tanyia Pillay, Martin P Grobusch, Heather J Zar | 181-182 |
Research
| Systematic review of the evidence for rational dosing of colistin | |
| E Visser Kift, G Maaartens, C Bamford | 183-186 |
| Determinants, outcomes and costs of ceftriaxone v. amoxicillin-clavulanate in the treatment of community-acquired pneumonia at Witbank Hospital | |
| S N Xaba, O Greeff, P Becker | 187-191 |
| The impact of chronic pseudomonal infection on pulmonary function testing in individuals with cystic fibrosis in Pretoria, South Africa | |
| A Pentz, P Becker, R Masekela, O Coetzee, R J Green | 191-194 |
| Cardiometabolic markers to identify cardiovascular disease risk in HIV-infected black South Africans | |
| J M van Rooyen, C M T Fourie, H S Steyn, G Koekemoer, H W Huisman, R Schutte, L Malan, M Glyn, W Smith, C Mels, A E Schutte | 195-199 |
| High pleural fluid adenosine deaminase levels: A valuable tool for rapid diagnosis of pleural TB in a middle-income country with a high TB/HIV burden | |
| C P Onyenekwu, A E Zemlin, R T Erasmus | 200-203 |
| Integration of TB and ART services fails to improve TB treatment outcomes: Comparison of ART/TB primary healthcare services in Cape Town, South Africa | |
| R Kaplan, J Caldwell, L-G Bekker, K Jennings, C Lombard, D A Enarson, R Wood, N Beyers | 204-209 |
| Tuberculosis incidence in Cameroonian prisons: A 1-year prospective study | |
| J Noeske, N F Ndi, G Amougou Elo, S Mbondi Mfondih | 209-211 |
Continuing Medical Education
| Spina bifida: A few simple facts about a complex condition | |
| Graham Fieggen | 212 |
| Spina bifida: A multidisciplinary perspective on a many-faceted condition | |
| Graham Fieggen, K Fieggen, C Stewart, L Padayachy, J Lazarus, K Donald, S Dix-Peek, Z Toefy, A Figaji | 213-217 |
| Aetiology and antenatal diagnosis of spina bifida | |
| Karen Fieggen, Chantal Stewart | 218 |
| Perinatal management of spina bifida | |
| Llewellyn Padayachy, Dan Ochieng’ | 219 |
| The paediatric neuropathic bladder | |
| John Lazarus | 220 |
| An approach to the developmental and cognitive profile of the child with spina bifida | |
| Nerica Ramsundhar, Kirsty Donald | 221 |
CPD
| CPD questionnaire | |
Progress towards the Millennium Development Goals
| Progress towards the Millennium Development Goals in SA | |
| Yogan Pillay, Peter Barron | 223 |
| Successfully controlling malaria in South Africa | |
| L Blumberg, J Frean, D Moonasar, South African Malaria Elimination Committee | 224-227 |
| Effectiveness of pneumococcal conjugate vaccine and rotavirus vaccine introduction into the South African public immunisation programme | |
| S A Madhi, L Bamford, N Ngcobo | 228-234 |
| Laboratory information system data demonstrate successful implementation of the prevention of mother-to-child transmission programme in South Africa | |
| G G Sherman, R R Lilian, S Bhardwaj, S Candy, P Barron | 235-238 |
| Elimination of mother-to-child transmission of HIV in South Africa: Rapid scale-up using quality improvement | |
| S Bhardwaj, P Barron, Y Pillay, L Treger-Slavin, P Robinson, A Goga, G Sherman | 239-243 |
| Tuberculosis control in South Africa: Successes, challenges and recommendations | |
| G J Churchyard, L D Mametja, L Mvusi, N Ndjeka, A C Hesseling, A Reid, S Babatunde, Y Pillay | 244-248 |
| A brief history of South Africa's response to AIDS | |
| N P Simelela, W D F Venter | 249-251 |